EPO Patents = 3

Forward Citations = 21

Loading Chart...

6 inventors (with patents filed for the assignee):

Fahar Merchant (12 out of 13 patents)

Raj K Puri (2 out of 15 patents)

Bharatkumar H Joshi (2 out of 4 patents)

4. Shafique Fidai (2 out of 2 patents)

5. Kenan Christopher Garcia (1 out of 41 patents)

6. Ignacio Moraga Gonzalez (1 out of 7 patents)

12 patents: Sort by Forward Citations

1. 12702710 - COMBINATION THERAPY OF MDNA55 AND A VASCULAR ENDOTHELIAL GROWTH FACTOR A (VEGF-A) (2026-08-11),

2. 12590133 - IL-13/IL-4 SUPERKINES: IMMUNE CELL TARGETING CONSTRUCTS AND METHODS OF USE THEREOF (2026-03-31),

3. 12404497 - Uses and methods for oncolytic virus targeting of IL-4/IL-13 and fusions thereof (2025-09-02),

4. 12338269 - IL-2 superagonists in combination with anti-PD-1 antibodies (2025-06-24),

5. 12274735 - IL-4-fusion formulations for treatment of central nervous system (CNS) tumors (2025-04-14),

6. 11680090 - Interleukin-2 fusion proteins and uses thereof (2023-06-20),

7. 11542312 - IL-2 superagonists in combination with anti-PD-1 antibodies (2023-01-03),

8. 11352402 - Interleukin-4 receptor-binding fusion proteins and uses thereof (2022-06-07),

9. 11084856 - Interleukin-4 receptor-binding fusion proteins and uses thereof (2021-08-10),

10. 10781242 - Interleukin-2 fusion proteins and uses thereof (2020-09-22),

11. 10106592 - Interleukin-4 receptor-binding fusion proteins and uses thereof (2018-10-23),

12. 10093708 - Interleukin-4 receptor-binding fusion proteins and uses thereof (2018-10-09),

Company Overview

Medicenna Therapeutics, Inc. is a biotechnology company based in Vancouver, Canada, focused on developing innovative therapies for cancer treatment. The company specializes in the design and manufacture of novel immunotherapies, particularly those that harness the power of the immune system to target and destroy cancer cells. Medicenna's research emphasizes the development of its proprietary platform technologies, which aim to enhance the efficacy and safety of cancer treatments, addressing significant unmet medical needs in oncology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

12 Patents

#77 in Vancouver

#1,266 in Canada

#48,209 in the World

Vancouver, Canada

Medicenna Therapeutics, Inc.

Forward Citations = 21

6 inventors:

Fahar Merchant (12 out of 13 patents)

Raj K Puri (2 out of 15 patents)

Bharatkumar H Joshi (2 out of 4 patents)

4. Shafique Fidai (2 out of 2 patents)

5. Kenan Christopher Garcia (1 out of 41 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Medicenna Therapeutics, Inc.. Retrieved from https://idiyas.com/company/medicenna-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]